Botanical Extract Combination Therapy for Viral Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for coronaviruses, such as SARS, MERS, and COVID-19, are limited, necessitating the development of effective antiviral therapies to address the lack of potent treatments for viral infections.
Innovation Solution
A combination therapy using andrographolide or its derivatives, ursolic acid, and piceid, or their pharmaceutically acceptable salts, is proposed, which can be administered alone or with additional antiviral agents, to target viral receptors and inhibit viral replication.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If combination therapy using andrographolide, ursolic acid, and piceid is employed, then antiviral activity is improved, but treatment complexity increases
Solution Approach 1:
The patent combines three distinct compounds (andrographolide, ursolic acid, and piceid) into a single therapeutic regimen. This merging of multiple antiviral agents with different mechanisms of action creates a synergistic effect that enhances overall antiviral activity while managing the complexity through a fixed combination protocol
Solution Approach 2:
The treatment utilizes a composite therapeutic approach by integrating three compounds with complementary antiviral mechanisms. Each compound targets different aspects of viral replication and entry, creating a multi-faceted antiviral strategy that addresses various stages of the viral lifecycle
2Reliability
If combination therapy with multiple compounds is used, then antiviral efficacy is improved, but manufacturing complexity increases
Solution Approach 1:
The patent merges three separately manufacturable compounds into a single combination product. This allows each compound to be produced using established manufacturing processes for individual natural product derivatives, while the combination itself can be formulated as a fixed-dose regimen or separate administration protocol
Solution Approach 2:
The combination therapy can be segmented into three separate but coordinated treatments, allowing each compound to be manufactured, quality-controlled, and dosed independently. This segmentation simplifies manufacturing by avoiding the need to create entirely new complex formulations, while still achieving the therapeutic benefits of combination therapy
Data Source
AI summary
The invention relates generally to combinations and compositions comprising botanical extracts useful in the treatment or prevention of viral and bacterial infections. In particular, the invention relates to combinations and compositions comprising two or more compounds selected from andrographolide or a derivative, or pharmaceutically acceptable salt thereof, ursolic acid, or a pharmaceutically acceptable salt thereof, and piceid or a derivative, or pharmaceutically acceptable salt thereof and use of the combinations and compositions in the treatment or prevention of viral and bacterial infections.